Skip to content

Prognostic Factors in NOP-LBBB After TAVI

Prognostic Factors in New-Onset Persistent Left Bundle Branch Block After Transcathether Aortic Valve Implantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05654792
Acronym
ProgNOP-LBBB
Enrollment
230
Registered
2022-12-16
Start date
2022-12-10
Completion date
2023-05-01
Last updated
2022-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transcatheter Aortic Valve Replacement

Keywords

transcatheter aortic valve implantation, aortic stenosis, permanent pacemaker, left bundle branch block, heart failure, cardiac dyssynchrony

Brief summary

The goal of this observational study is to find prognostic factors in patients with a new-onset persistent left bundle branch block (NOP-LBBB) after transcatheter aortic valve implantation (TAVI). The main question it aims to answer is: Are there any factors influencing heart failure or death risk during the year following TAVI in patients with NOP-LBBB ? Participants will have data collection about TAVI procedure and clinical evolution during a one-year follow-up.

Interventions

DEVICETranscatheter aortic valve implantation

Transcatheter aortic valve implantation in cases of severe aortic stenosis

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* New-onset persistent left bundle branch block after transcatheter aortic valve implantation

Exclusion criteria

* Pre-existing left bundle branch block * Pre-existing right bundle branch block * Pre-existing permanent pacemaker * Immediate procedural mortality (death ≤72 h post-procedure)

Design outcomes

Primary

MeasureTime frameDescription
Hospitalisation for heart failure or all-cause mortalityAt one-year after transcatheter aortic valve implantationHospitalisation for heart failure or all-cause mortality

Secondary

MeasureTime frameDescription
Hospitalisation for heart failureAt one-year after transcatheter aortic valve implantationHospitalisation for heart failure
All-cause mortalityAt one-year after transcatheter aortic valve implantationAll-cause mortality

Contacts

Primary ContactMathieu ECHIVARD, PhD
m.echivard@chru-nancy.fr+3383157356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026